Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 5 clinical trials
Vandetanib and Everolimus in Treating Patients With Advanced or Metastatic Cancer

This phase I trial studies the side effects and best dose of vandetanib and everolimus when given together in treating patients with cancer that has spread to other places in the body

absolute neutrophil count
metastasis
neutrophil count
palliative radiation therapy
cancer
  • 0 views
  • 28 Jun, 2021
  • 1 location
Ponatinib in Advanced or Metastatic Medullary Thyroid Cancer

previously treated with cabozantinib or vandetanib who have tumors with rearranged-during-transfection (RET) mutations and have tumors without RET mutations.

  • 0 views
  • 24 May, 2021
  • 1 location
A Phase I Dose Escalation Study for Patients With Recurrent Malignant Gliomas

the study is to find out the highest dose of vandetanib that can be safely given with repeat radiation therapy. Vandetanib will be called "study drug" in the remainder of this consent form

  • 7 views
  • 07 Nov, 2020
  • 1 location
Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy

The purpose of this study is to evaluate the efficacy and feasibility of combination chemotherapy with target agents according to the result of targeted deep sequencing in pediatric patients with relapsed/refractory solid tumor or AML.

etoposide
fludarabine
imatinib
ifosfamide
cytarabine
  • 0 views
  • 24 Jan, 2021
  • 1 location
Natural History Study of Children and Adults With Medullary Thyroid Cancer

Background Medullary thyroid cancer (MTC) is a rare cancer of the thyroid gland. In children and adults, it is often part of a condition called Multiple Endocrine Neoplasia 2 (MEN2). MEN2 is usually caused by a genetic mutation, and it can cause a number of problems in addition to MTC. …

  • 0 views
  • 12 Sep, 2021
  • 1 location